These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 8175127)

  • 1. A multicenter study on the prognosis of fulminant viral hepatitis: early prediction for liver transplantation.
    Takahashi Y; Kumada H; Shimizu M; Tanikawa K; Kumashiro R; Omata M; Ehata T; Tsuji T; Ukida M; Yasunaga M
    Hepatology; 1994 May; 19(5):1065-71. PubMed ID: 8175127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fulminant hepatitis in a tropical population: clinical course, cause, and early predictors of outcome.
    Acharya SK; Dasarathy S; Kumer TL; Sushma S; Prasanna KS; Tandon A; Sreenivas V; Nijhawan S; Panda SK; Nanda SK; Irshad M; Joshi YK; Duttagupta S; Tandon RK; Tandon BN
    Hepatology; 1996 Jun; 23(6):1448-55. PubMed ID: 8675163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of hepatitis C virus to non-A, non-B fulminant hepatitis in Japan.
    Yoshiba M; Dehara K; Inoue K; Okamoto H; Mayumi M
    Hepatology; 1994 Apr; 19(4):829-35. PubMed ID: 8138253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation.
    Toniutto P; Fabris C; Bitetto D; Falleti E; Avellini C; Rossi E; Smirne C; Minisini R; Pirisi M
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1904-8. PubMed ID: 17914968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic assessment of fulminant hepatitis from indication criteria for liver transplantation.
    Watanabe A; Shiota T; Tsuji T
    J Med; 1992; 23(1):39-49. PubMed ID: 1374114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prediction of fulminant hepatitis in severe acute hepatitis B].
    Michitaka K; Onji M
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():269-73. PubMed ID: 15453328
    [No Abstract]   [Full Text] [Related]  

  • 7. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
    Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
    Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fulminant liver failure from acute autochthonous hepatitis E in France: description of seven patients with acute hepatitis E and encephalopathy.
    Péron JM; Bureau C; Poirson H; Mansuy JM; Alric L; Selves J; Dupuis E; Izopet J; Vinel JP
    J Viral Hepat; 2007 May; 14(5):298-303. PubMed ID: 17439518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible risk factors for the transmission of hepatitis E virus and for the severe form of hepatitis E acquired locally in Hokkaido, Japan.
    Mizuo H; Yazaki Y; Sugawara K; Tsuda F; Takahashi M; Nishizawa T; Okamoto H
    J Med Virol; 2005 Jul; 76(3):341-9. PubMed ID: 15902701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of the prognosis after liver transplantation in severe hepatitis B-induced liver failure and clinical decision for liver transplantation.
    Yang X; Lu Q; Tang T; Liao R; Yang Z
    J Surg Res; 2013 Aug; 183(2):846-51. PubMed ID: 23434208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 1-year and 3-month prognostic utility of the AST/ALT ratio and model for end-stage liver disease score in patients with viral liver cirrhosis.
    Giannini E; Botta F; Testa E; Romagnoli P; Polegato S; Malfatti F; Fumagalli A; Chiarbonello B; Risso D; Testa R
    Am J Gastroenterol; 2002 Nov; 97(11):2855-60. PubMed ID: 12425560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic indicators in fulminant hepatic failure.
    Frohburg E; Stölzel U; Lenz K; Schäfer JH; Tung LC; Riecken EO
    Z Gastroenterol; 1992 Sep; 30(9):571-5. PubMed ID: 1449004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of non-invasive indices for liver histology in patients with chronic hepatitis B].
    Chen YP; Zhu YF; Feng XR; Peng J; Hou JL
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Oct; 24(10):1181-3. PubMed ID: 15485795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome after liver re-transplantation in patients with recurrent chronic hepatitis C.
    Bahra M; Neumann UP; Jacob D; Berg T; Neuhaus R; Langrehr JM; Neuhaus P
    Transpl Int; 2007 Sep; 20(9):771-8. PubMed ID: 17617179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experience.
    Tillmann HL; Hadem J; Leifeld L; Zachou K; Canbay A; Eisenbach C; Graziadei I; Encke J; Schmidt H; Vogel W; Schneider A; Spengler U; Gerken G; Dalekos GN; Wedemeyer H; Manns MP
    J Viral Hepat; 2006 Apr; 13(4):256-63. PubMed ID: 16611192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An eleven year survey (1975-1985) of fulminant hepatitis: considerations on epidemiology and pathogenesis.
    Scevola D; Barbarini G; Michelone G; Calderon W; Dughetti S
    Boll Ist Sieroter Milan; 1986; 65(6):453-8. PubMed ID: 3107592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.
    Fattovich G; Pantalena M; Zagni I; Realdi G; Schalm SW; Christensen E;
    Am J Gastroenterol; 2002 Nov; 97(11):2886-95. PubMed ID: 12425564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The serum glutamic oxaloacetic transaminase/serum glutamic pyruvic transaminase ratio as a prognostic index in severe acute viral hepatitis.
    Gitlin N
    Am J Gastroenterol; 1982 Jan; 77(1):2-4. PubMed ID: 6801971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of non A, non B, non C hepatitis that relapsed into fulminant hepatic failure.
    Cuffari C; Brochu P; Russo P; Alvarez F
    Hepatogastroenterology; 1998; 45(24):2348-51. PubMed ID: 9951921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Predictors of massive blood transfusion in liver transplantation for patients with benign end-stage liver disease].
    Feng ZY; Jin XD; Chen YZ
    Zhonghua Yi Xue Za Zhi; 2008 Nov; 88(43):3040-4. PubMed ID: 19192401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.